neoplasm
• mice exhibit similar tumorigenesis as Atmintm1.1Jhh/Atmintm1.1Jhh Tg(Fcer2a-cre)5Mbu mice
|
Allele Symbol Allele Name Allele ID |
Ighmtm1(Bcl6)Rdf targeted mutation 1, Riccardo Dalla-Favera MGI:3581517 |
||||||||||||||||
Summary |
3 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• mice exhibit similar tumorigenesis as Atmintm1.1Jhh/Atmintm1.1Jhh Tg(Fcer2a-cre)5Mbu mice
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• Igh-6tm1(Bcl6)Rdf was unable to rescue the inflammatory phenotype observed in homozygous Bcl6 null mice
|
• although proliferation of B cells expressing germinal center markers was induced, the cells did not aggregate in typical germinal center structures
|
• although proliferation of B cells expressing germinal center markers was induced, the cells did not aggregate in typical germinal center structures
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• showed increased mortality at about 13 months of age and only about 80% survived at 15 months
|
• 42% exhibited abnormal B cell expansions involving predominately the spleen but also the lymph nodes compared to 11% in wild-type and displayed features of benign lymphoproliferative disease
|
• about a 30% reduction in the number of total plasmacytoid cells (B220+/- CD138+), mainly due to a decrease in post-CSR plasma cells (IgM-IgD-), while IgM+IgD+ plasma cells were normal
|
• 17% displayed a complete effacement of the splenic lymphoid architecture due to the proliferation of large lymphoid cells
|
• 17% exhibited a modest splenomegaly at 6 months of age
|
• partial effacement of the follicular architecture with the appearance of blast cells
|
• nonimmunized mutant mice displayed an increased number of germinal centers, comparable to that observed upon immunization in wild-type mice, and the increase in the number of germinal centers and an increase in the total germinal center area persisted after immunization
|
• expanded white pulp composed predominately of B cells, but also included disorganized accumulations of other cell types such as T cells and dendritic cells
|
• displayed a small (20-50%) reduction in total serum immunoglobulin levels of all subclasses, except for IgM, both under basal conditions and after immunization with T-dependent antigens
|
• between 15 and 20 months, 36-62% developed clonal B cell lymphomas, predominately of splenic orgin, with or without nodal involvement
• tumors displayed a mature B cell phenotype and most were histologically reminiscent of human diffuse large B cell lymphomas and contained clonal karyotypic aberrations
|
• 42% exhibited abnormal B cell expansions involving predominately the spleen but also the lymph nodes compared to 11% in wild-type and displayed features of benign lymphoproliferative disease
|
• about a 30% reduction in the number of total plasmacytoid cells (B220+/- CD138+), mainly due to a decrease in post-CSR plasma cells (IgM-IgD-), while IgM+IgD+ plasma cells were normal
|
• 17% displayed a complete effacement of the splenic lymphoid architecture due to the proliferation of large lymphoid cells
|
• 17% exhibited a modest splenomegaly at 6 months of age
|
• partial effacement of the follicular architecture with the appearance of blast cells
|
• nonimmunized mutant mice displayed an increased number of germinal centers, comparable to that observed upon immunization in wild-type mice, and the increase in the number of germinal centers and an increase in the total germinal center area persisted after immunization
|
• expanded white pulp composed predominately of B cells, but also included disorganized accumulations of other cell types such as T cells and dendritic cells
|
• displayed a small (20-50%) reduction in total serum immunoglobulin levels of all subclasses, except for IgM, both under basal conditions and after immunization with T-dependent antigens
|
• 17% exhibited a modest splenomegaly at 6 months of age
|
• 42% exhibited abnormal B cell expansions involving predominately the spleen but also the lymph nodes compared to 11% in wild-type and displayed features of benign lymphoproliferative disease
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
non-Hodgkin lymphoma | DOID:0060060 |
OMIM:605027 |
J:98937 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
![]() |
|